Akron Children’s, CareSource to launch ACO
Dubbed the Akron Children's Health Collaborative, the pediatric ACO will focus on improving care for the approximately 100,000 children in Ohio covered by Medicaid whose benefits are managed by CareSource.
Dubbed the Akron Children's Health Collaborative, the pediatric ACO will focus on improving care for the approximately 100,000 children in Ohio covered by Medicaid whose benefits are managed by CareSource.
With the CDC’s eviction moratorium set to lift at the end of the month, many people are still struggling with rent payments and utility debt. Insurance and healthcare technology leaders shared how they’re preparing and what’s needed to address the housing shortage in the long term.
Don't tell CareSource that this year's controversial health reform package is going to destroy America. What's likely to hurt Democrats at the polls next month may help bring 500 jobs to Dayton as managed care provider CareSource looks to grow.
News and notes from the day in MedCity, Ohio: University Hospitals Case Medical Center’s first spinoff company Fluence Therapeutics Inc. recently opened in the downtown Akron Global Business Accelerator on South Main Street, the Akron Beacon Journal reported. The start-up comes from more than 20 years of research on a psoriasis treatment known as photodynamic […]
Hospitals nationwide have created observation units to watch patients for a few hours or a few days without admitting them, according to the Columbus Dispatch. The practice can cut cost of billing by one-third, and insurers are more likely to cover the cost.
The U.S. Department of Justice has sued Johnson & Johnson, accusing it of paying Omnicare Inc. in Covington, Ky., millions of dollars in kickbacks to buy and recommend J&J's drugs for patients in nursing homes.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
The University of Cincinnati College of Medicine has launched an early stage cancer drug development program and phase-1 clinical trials unit for patients who have solid tumors that have resisted cancer therapies.